Opioids
Washington (AFP) - The US Supreme Court on Thursday rejected Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation. In a 5-4 ruling, the judges agreed with the Justice Department which argued that the Sacklers, who earned tens of billions of dollars flooding the country with highly addictive opioids, should not gain sweeping legal protection in the controversial deal. The court held that "the bankruptcy code does not authorize this kind of order," with the majority opinion written by Neil Gorsuch and joined by Claren...
AFP
After OxyContin manufacturer Purdue Pharma filed for Chapter 11 bankruptcy in 2019, members of the Sackler family, which controlled the company, arranged a resolution that included personal protection from civil liability for contributing to opioid-related deaths. That shield was part of a mass settlement that promised myriad litigants a total of $6 billion. The Supreme Court narrowly rejected that deal today. "The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, effectively seeks to discharge claims against a nondebtor wit...
Reason
In a 5-4 vote, the court ruled that the Sackler family cannot be shielded from future claims through Purdue’s bankruptcy. Since the case was first heard, victims of the opioid crisis and recovery advocates have been split on the desired outcome. Some wanted the bankruptcy deal to go through so that settlement money could start flowing and fund urgently needed addiction services. Others said it would be unacceptable to allow the Sacklers to evade responsibility for their actions. If you enjoyed this breakdown, follow the KFF Health News social team on Instagram @KFFHealthNews. ✍️: Aneri Pattani...
Kaiser Health News
In a 5-4 vote, the court ruled that the Sackler family cannot be shielded from future claims through Purdue’s bankruptcy. Since the case was first heard, victims of the opioid crisis and recovery advocates have been split on the desired outcome. Some wanted the bankruptcy deal to go through so that settlement money could start flowing and fund urgently needed addiction services. Others said it would be unacceptable to allow the Sacklers to evade responsibility for their actions. If you enjoyed this breakdown, follow the KFF Health News social team on Instagram @KFFHealthNews. ✍️: Aneri Pattani...
California Healthline
On July 1, new laws will go into effect in a number%20%E2%80%94%20Hundreds%20of,carrying%20guns%20in%20certain%20areas) of U.S. states. One Tennessee law would make suspicion of opioid impairment sufficient to establish evidence of driving under the influence. In August 2023, Ben Kredich was struck and killed when a vehicle swerved off the road. The driver, Shannon Walker, had apparently passed out behind the wheel while under the influence of opioids; in April, a grand jury indicted Walker on charges including vehicular homicide, driving under the influence, and possession of controlled subst...
Reason
Opioid manufacturers, distributors, and retailers are paying tens of billions of dollars in restitution to settle lawsuits related to their role in the nation’s overdose epidemic. A recent broadcast of “Last Week Tonight With John Oliver” examined how that money is being spent by state and local governments across the United States. The segment featured reporting from the KFF Health News series “Payback: Tracking the Opioid Settlement Cash.” You can learn more about the issue and read our collection of articles by Aneri Pattani here.
Kaiser Health News
Opioid manufacturers, distributors, and retailers are paying tens of billions of dollars in restitution to settle lawsuits related to their role in the nation’s overdose epidemic. A recent broadcast of “Last Week Tonight With John Oliver” examined how that money is being spent by state and local governments across the United States. The segment featured reporting from the KFF Health News series “Payback: Tracking the Opioid Settlement Cash.” You can learn more about the issue and read our collection of articles by Aneri Pattani here. KFF Health News is a national newsroom that produces in-dept...
California Healthline
On a narrow street lined with row houses and an auto body shop in the Kensington neighborhood of North Philadelphia, Marsella Elie climbs a home’s front steps and knocks hard on the door. A middle-aged man appears with a wary look on his face. “Hello, sir, how are you doing today?” asked Elie, wearing a royal-blue jacket embroidered with the city government’s Liberty Bell logo. “My name is Marsella. I’m working with the city. You heard about the overdoses that are going around in the neighborhood, right?” The man gives a cautious nod. Elie gestures to the pamphlets she’s holding about drug ove...
Kaiser Health News
New York (AFP) - Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday. Publicis Health, part of the French advertising giant Publicis, worked with Purdue Pharma between 2010 and 2019 on marketing material to promote OxyContin and other drugs, New York Attorney General Letitia James said in a press release. She said the agreement was the first with an advertising agency for its role in the opioid epidemic. "For a decade, Publicis helped opioid manufac...
AFP
Washington (AFP) - The US drug regulator announced Wednesday that Narcan, the treatment which reverses overdoses, can be distributed without prescription, a move that comes as the country battles an acute opioid addiction crisis. The Federal Drug Administration (FDA) said that four milligram nasal spray doses of naloxone hydrochloride, the generic name for Narcan, can be sold over the counter almost anywhere, from pharmacies to supermarkets to gas stations. The FDA said they moved to address to mounting toll from opioid use, especially the synthetic and relatively easily made fentanyl, which h...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら